Literature DB >> 10208233

Severe intrapulmonary shunting associated with metastatic carcinoid.

D F Lee1, L S Lepler.   

Abstract

A 37-year-old woman with a 10-year history of metastatic carcinoid presented to her oncologist with increased dyspnea. Further evaluation revealed hypoxemia and intrapulmonary vasodilatation. We describe a case of hepatopulmonary-like physiology associated with metastatic carcinoid in a patient with intact liver function. To our knowledge, this is the first documented case of intrapulmonary shunting and hepatopulmonary-like physiology associated with metastatic carcinoid.

Entities:  

Mesh:

Year:  1999        PMID: 10208233     DOI: 10.1378/chest.115.4.1203

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

Review 1.  Hepatopulmonary syndrome.

Authors:  M B Fallon; G A Abrams
Journal:  Curr Gastroenterol Rep       Date:  2000-02

2.  [Progressive dyspnoea in two patients with carcinoid syndrome].

Authors:  S Nölting; M Nicolaus; J Behr; R Baumgartner; H Mete; P Boekstegers; K Herrmann; D Theisen; M Lehrke; B Göke; J Schirra; C J Auernhammer
Journal:  Internist (Berl)       Date:  2010-11       Impact factor: 0.743

Review 3.  Hepatopulmonary syndrome: update on pathogenesis and clinical features.

Authors:  Junlan Zhang; Michael B Fallon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

4.  Palliative embolisation for intrapulmonary shunting in lepidic predominant adenocarcinoma of the lung.

Authors:  Joanne Yue-Ai Tan; Darren L Walters; Karl Poon; Paul Zimmerman; Pat Aldons
Journal:  Respir Med Case Rep       Date:  2015-05-27

5.  Development of severe intrapulmonary shunting in a patient with carcinoid heart disease after closure of a persistent foramen ovale: a case report.

Authors:  Dominik Schüttler; Konstantinos Mourouzis; Christoph J Auernhammer; Konstantinos D Rizas
Journal:  Eur Heart J Case Rep       Date:  2021-12-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.